Shanghai Shen Lian Biomedical Corporation
public_traded
Shanghai Shen Lian Biomedical Corporation is publicly traded on SHH under ticker 688098.SS.
Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China.